Spineguard (ALSGD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.172x

Based on the latest financial reports, Spineguard (ALSGD) has a cash flow conversion efficiency ratio of -0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-738.46K ≈ $-863.33K USD) by net assets (€4.28 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Spineguard - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Spineguard's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Spineguard for a breakdown of total debt and financial obligations.

Spineguard Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spineguard ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ZIGUP plc LSE:ZIG	0.224x
Canaf Investments Inc V:CAF	0.057x
Aston Bay Holdings Ltd V:BAY	-0.966x
SRJ Technologies Group Plc AU:SRJ	-0.052x
IRLAB Therapeutics AB (publ) ST:IRLAB-A	0.097x
LDT Inc KQ:096870	0.027x
Idealist Gayrimenkul Yatirim Ortakligi AS IS:IDGYO	0.687x
TSR Capital Bhd KLSE:5042	0.074x

Annual Cash Flow Conversion Efficiency for Spineguard (2011–2024)

The table below shows the annual cash flow conversion efficiency of Spineguard from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Spineguard stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€3.90 Million ≈ $4.56 Million	€-2.35 Million ≈ $-2.74 Million	-0.601x	+0.63%
2023-12-31	€6.03 Million ≈ $7.05 Million	€-3.65 Million ≈ $-4.27 Million	-0.605x	-74.67%
2022-12-31	€5.14 Million ≈ $6.01 Million	€-1.78 Million ≈ $-2.08 Million	-0.346x	-51.31%
2021-12-31	€5.05 Million ≈ $5.90 Million	€-1.16 Million ≈ $-1.35 Million	-0.229x	-100.22%
2020-12-31	€-8.93K ≈ $-10.44K	€-948.67K ≈ $-1.11 Million	106.257x	+27931.10%
2019-12-31	€592.03K ≈ $692.15K	€224.42K ≈ $262.37K	0.379x	-72.27%
2018-12-31	€-489.56K ≈ $-572.35K	€-669.26K ≈ $-782.44K	1.367x	-88.66%
2017-12-31	€-208.50K ≈ $-243.75K	€-2.51 Million ≈ $-2.94 Million	12.051x	+455.49%
2016-12-31	€1.19 Million ≈ $1.39 Million	€-4.03 Million ≈ $-4.72 Million	-3.390x	-518.39%
2015-12-31	€4.73 Million ≈ $5.54 Million	€-2.60 Million ≈ $-3.03 Million	-0.548x	+4.69%
2014-12-31	€5.77 Million ≈ $6.74 Million	€-3.32 Million ≈ $-3.88 Million	-0.575x	-71.23%
2013-12-31	€8.92 Million ≈ $10.42 Million	€-2.99 Million ≈ $-3.50 Million	-0.336x	+39.27%
2012-12-31	€5.32 Million ≈ $6.22 Million	€-2.94 Million ≈ $-3.44 Million	-0.553x	-106.39%
2011-12-31	€7.15 Million ≈ $8.36 Million	€-1.92 Million ≈ $-2.24 Million	-0.268x	--

About Spineguard

PA:ALSGD France Medical Devices

Market Cap

$10.98 Million

€9.39 Million EUR

Market Cap Rank

#26642 Global

#461 in France

Share Price

€0.10

Change (1 day)

+1.94%

52-Week Range

€0.08 - €0.19

All Time High

€5.18